These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30422000)

  • 1. TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis.
    Rego SL; Harvey S; Simpson SR; Hemphill WO; McIver ZA; Grayson JM; Perrino FW
    Autoimmunity; 2018 Nov; 51(7):333-344. PubMed ID: 30422000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.
    Grieves JL; Fye JM; Harvey S; Grayson JM; Hollis T; Perrino FW
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5117-22. PubMed ID: 25848017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Bcl6 in the TREX1 D18N murine model ameliorates autoimmunity by modulating T-follicular helper cells and germinal center B cells.
    Venkatadri R; Sabapathy V; Dogan M; Mohammad S; Harvey SE; Simpson SR; Grayson JM; Yan N; Perrino FW; Sharma R
    Eur J Immunol; 2022 May; 52(5):825-834. PubMed ID: 35112355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
    Lehtinen DA; Harvey S; Mulcahy MJ; Hollis T; Perrino FW
    J Biol Chem; 2008 Nov; 283(46):31649-56. PubMed ID: 18805785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model.
    Xiao N; Wei J; Xu S; Du H; Huang M; Zhang S; Ye W; Sun L; Chen Q
    J Autoimmun; 2019 Jun; 100():84-94. PubMed ID: 30872080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome.
    Fye JM; Orebaugh CD; Coffin SR; Hollis T; Perrino FW
    J Biol Chem; 2011 Sep; 286(37):32373-82. PubMed ID: 21808053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Arg-62 residues of the TREX1 exonuclease act across the dimer interface contributing to catalysis in the opposing protomers.
    Fye JM; Coffin SR; Orebaugh CD; Hollis T; Perrino FW
    J Biol Chem; 2014 Apr; 289(16):11556-11565. PubMed ID: 24616097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T Cells Produce IFN-α in the TREX1 D18N Model of Lupus-like Autoimmunity.
    Simpson SR; Rego SL; Harvey SE; Liu M; Hemphill WO; Venkatadri R; Sharma R; Grayson JM; Perrino FW
    J Immunol; 2020 Jan; 204(2):348-359. PubMed ID: 31826941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice.
    Sakai T; Miyazaki T; Shin DM; Kim YS; Qi CF; Fariss R; Munasinghe J; Wang H; Kovalchuk AL; Kothari PH; Fermaintt CS; Atkinson JP; Perrino FW; Yan N; Morse HC
    J Autoimmun; 2017 Jul; 81():13-23. PubMed ID: 28325644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in DNA degradation revealed in crystal structures of TREX1 exonuclease mutations linked to autoimmune disease.
    Bailey SL; Harvey S; Perrino FW; Hollis T
    DNA Repair (Amst); 2012 Jan; 11(1):65-73. PubMed ID: 22071149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.
    Lee-Kirsch MA; Chowdhury D; Harvey S; Gong M; Senenko L; Engel K; Pfeiffer C; Hollis T; Gahr M; Perrino FW; Lieberman J; Hubner N
    J Mol Med (Berl); 2007 May; 85(5):531-7. PubMed ID: 17440703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease.
    Lindahl T; Barnes DE; Yang YG; Robins P
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):535-8. PubMed ID: 19442247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aicardi-Goutières syndrome protein TREX1 suppresses L1 and maintains genome integrity through exonuclease-independent ORF1p depletion.
    Li P; Du J; Goodier JL; Hou J; Kang J; Kazazian HH; Zhao K; Yu XF
    Nucleic Acids Res; 2017 May; 45(8):4619-4631. PubMed ID: 28334850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cyclic GMP-AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1-Deficient Mice.
    An J; Woodward JJ; Lai W; Minie M; Sun X; Tanaka L; Snyder JM; Sasaki T; Elkon KB
    Arthritis Rheumatol; 2018 Nov; 70(11):1807-1819. PubMed ID: 29781188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREX1 - Apex predator of cytosolic DNA metabolism.
    Simpson SR; Hemphill WO; Hudson T; Perrino FW
    DNA Repair (Amst); 2020 Oct; 94():102894. PubMed ID: 32615442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs.
    Achleitner M; Kleefisch M; Hennig A; Peschke K; Polikarpova A; Oertel R; Gabriel B; Schulze L; Lindeman D; Gerbaulet A; Fiebig U; Lee-Kirsch MA; Roers A; Behrendt R
    J Immunol; 2017 Oct; 199(7):2261-2269. PubMed ID: 28835460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exonuclease Trex1 restrains macrophage proinflammatory activation.
    Pereira-Lopes S; Celhar T; Sans-Fons G; Serra M; Fairhurst AM; Lloberas J; Celada A
    J Immunol; 2013 Dec; 191(12):6128-35. PubMed ID: 24218451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases.
    Gao D; Li T; Li XD; Chen X; Li QZ; Wight-Carter M; Chen ZJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5699-705. PubMed ID: 26371324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
    Zimmermann N; Wolf C; Schwenke R; Lüth A; Schmidt F; Engel K; Lee-Kirsch MA; Günther C
    JAMA Dermatol; 2019 Mar; 155(3):342-346. PubMed ID: 30673078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.